标普生物科技LOF(161127)
动态评分: 5.92分
投资组合

报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
2017-12-31 | VNDA | Vanda Pharmaceuticals Inc | 34.24 | 0.43% |
2017-12-31 | KERX | 克律克斯生物制药 | 33.31 | 0.42% |
2017-12-31 | RGNX | REGENXBIO Inc | 33.35 | 0.42% |
2017-12-31 | NTLA | Intellia Therapeutics Inc | 32.72 | 0.41% |
2017-12-31 | CARA | Cara Therapeutics Inc | 30.66 | 0.39% |
2017-12-31 | ENTA | Enanta Pharmaceuticals Inc | 30.1 | 0.38% |
2017-12-31 | LJPC | La Jolla Pharmaceutical Co | 29.71 | 0.38% |
2017-12-31 | EPZM | Epizyme Inc | 25.18 | 0.32% |
2017-12-31 | LXRX | 莱斯康制药 | 25.33 | 0.32% |
2017-12-31 | TCRT | Alaunos Therapeutics Inc | 24.23 | 0.31% |
2017-12-31 | MRTX | Mirati Therapeutics Inc | 22.81 | 0.29% |
2017-12-31 | CTMX | CytomX Therapeutics Inc | 21.06 | 0.27% |
2017-12-31 | CYTK | Cytokinetics Inc | 21.48 | 0.27% |
2017-12-31 | CHRS | Coherus BioSciences Inc | 20.43 | 0.26% |
2017-12-31 | FMI | Foundation Medicine Inc | 20.86 | 0.26% |
2017-12-31 | BCRX | BioCryst Pharmaceuticals Inc | 19.37 | 0.25% |
2017-12-31 | AKBA | Akebia Therapeutics Inc | 19.01 | 0.24% |
2017-12-31 | INO | Inovio制药 | 19.11 | 0.24% |
2017-12-31 | TVTX | Travere Therapeutics Inc | 18.74 | 0.24% |
2017-12-31 | PGNX | 普罗基尼克斯制药 | 18.17 | 0.23% |
公告&资料
